HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bayer Bullish On Consumer Health’s Prospects Despite ‘Challenging’ 2018

Executive Summary

Notwithstanding a particularly difficult 2018, Bayer Consumer Health still has "one of the best brand portfolios," and can continue to compete with the market leaders, says CEO Werner Baumann. Consumer Health struggled particularly in the US and Europe in the 12 months, with the majority of its leading brands recording poor performances.

Related Content

Bayer's Consumer Health Struggles Continue In Q1, But The Firm Insists It's On The Right Track
Manufacturing Moves: Bayer Upgrades Americas Production, GSK To Shutter Nigeria Plant
Bayer's Canesten Switched From Rx-To-OTC Status In Poland
Bayer Launches Clarinaze Allergy Control Following Successful Rx-to-OTC Switch In UK
Bayer's Consumer Chief Initiates Turnaround Plan In Bid To Return Troubled Business To Growth
Coppertone, Dr. Scholl’s On The Block As Bayer Narrows Consumer Health Focus
Chinese switch hurts Bayer


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts